Physician

Mustafa A Hashem, MD

According to 2025 Medicare claims, Mustafa Hashem, MD (NPI: 1699777995) practices cardiology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is DOWNRIVER HEART AND VASCULAR SPECIALISTS PC (NPI: 1194838383; TIN: 38-2546610) and primary practice location at 48195-1302. Hashem is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Hashem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,727 traditional Medicare patients, billed 7,588 HCPCS/CPT codes, and received $691,789 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 13,159 prescription claims across 1,605 beneficiaries totaling $2,445,883 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 115 records totaling $2,502. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $851,363 to $691,789. In contrast, Part D prescription costs have moved sharply higher in recent years, from $296,289 to $2,445,883. For DME billing, this smaller-volume category rose steadily, from $1,693 to $30,922.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,405	6,069	$851,363
2016	3,171	10,507	$1,796,710
2017	3,883	13,205	$1,628,589
2018	3,392	12,125	$1,672,541
2019	2,860	11,598	$1,466,266
2020	2,121	10,480	$1,532,759
2021	2,032	10,224	$1,401,848
2022	1,786	10,175	$1,364,419
2023	1,578	8,937	$1,012,731
2024	1,727	7,588	$691,789

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	652	5,412	$296,289
2016	905	7,105	$383,096
2017	1,055	9,510	$634,598
2018	1,128	9,834	$764,510
2019	1,248	9,615	$919,860
2020	1,313	10,729	$1,158,469
2021	1,397	11,301	$1,326,102
2022	1,442	11,423	$1,504,128
2023	1,523	12,106	$2,025,576
2024	1,605	13,159	$2,445,883

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	21	$536
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	22	$423
2020	N/R	26	$815
2021	N/R	23	$52,180
2022	N/R	N/R	N/R
2023	N/R	13	$30,851
2024	N/R	11	$25,967

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	241	308	$97
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	345	347	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	635	1,060	$69
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	711	1,186	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	460	540	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	878	51,676	$959,666
Entresto	Sacubitril/Valsartan	384	22,710	$468,574
Jardiance	Empagliflozin	235	15,240	$286,677
Xarelto	Rivaroxaban	274	15,390	$265,831
Farxiga	Dapagliflozin Propanediol	118	6,039	$107,057

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0606	Automatic external defibrillator, with integrated electrocardiogram analysis, garment type	Y	N/R	11	$25,967

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	115	$2,502	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mustafa A. Hashem, MD?

Tedicare shows public-source Medicare data for Mustafa A. Hashem, MD (NPI 1699777995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mustafa A. Hashem, MD have ACO affiliation data?

Mustafa A. Hashem, MD is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Mustafa A. Hashem, MD?

Mustafa A. Hashem, MD is linked to DOWNRIVER HEART AND VASCULAR SPECIALISTS PC (billing NPI 1194838383) in the available physician profile data.

Does Mustafa A. Hashem, MD have Open Payments data?

Mustafa A. Hashem, MD has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.